145 related articles for article (PubMed ID: 36415210)
1. Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry.
Jandhyala R
F1000Res; 2022; 11():813. PubMed ID: 36415210
[No Abstract] [Full Text] [Related]
2. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method.
Jandhyala R; Rout R
Curr Med Res Opin; 2023 Dec; 39(12):1541-1550. PubMed ID: 36632732
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
Jandhyala R
Pharmaceut Med; 2022 Feb; 36(1):47-57. PubMed ID: 34994965
[TBL] [Abstract][Full Text] [Related]
4. Development, validation and implementation of the medical affairs pharmaceutical physician work-related quality of life instrument.
Jandhyala R
Curr Med Res Opin; 2023 Dec; 39(12):1567-1574. PubMed ID: 36719367
[TBL] [Abstract][Full Text] [Related]
5. Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.
Jandhyala R
Front Pharmacol; 2022; 13():842431. PubMed ID: 35273511
[No Abstract] [Full Text] [Related]
6. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
7. Evolving role of pharmaceutical physicians in medical evidence and education.
Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
[TBL] [Abstract][Full Text] [Related]
8. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
9. Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional Activities.
Kamal S; Holmberg C; Russell J; Bochenek T; Tobiasz-Adamczyk B; Fischer C; Tinnemann P
PLoS One; 2015; 10(10):e0140457. PubMed ID: 26473484
[TBL] [Abstract][Full Text] [Related]
10. Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan.
Maeda H
Front Med (Lausanne); 2021; 8():672095. PubMed ID: 34434941
[TBL] [Abstract][Full Text] [Related]
11. Encounters with pharmaceutical sales representatives among practicing internists.
Ferguson RP; Rhim E; Belizaire W; Egede L; Carter K; Lansdale T
Am J Med; 1999 Aug; 107(2):149-52. PubMed ID: 10460046
[TBL] [Abstract][Full Text] [Related]
12. Proposal of Standard for Medical Science Liaison (MSL) Profession in Japan: A Viewpoint from the Japanese Association of Pharmaceutical Medicine (JAPhMed).
Tomiyasu M; Hayashi K; Moritsugu Y; Miyachi N; Iwamoto K; Nitta M; Mori M; Iwasaki K
Pharmaceut Med; 2020 Oct; 34(5):315-326. PubMed ID: 33030675
[TBL] [Abstract][Full Text] [Related]
13. Medicine adaptive pathways to patients (MAPPs): using regulatory innovation to defeat Eroom's law.
Schulthess D; Chlebus M; Bergstrӧm R; Baelen KV
Chin Clin Oncol; 2014 Jun; 3(2):21. PubMed ID: 25841417
[TBL] [Abstract][Full Text] [Related]
14. Redefining the Role of Medical Affairs Professionals as Innovators and Leaders in Industry-Led Medical Education.
Setia S; Loo E; Shinde SP; Singh M; Wong CH; Thakkar K
Pharmaceut Med; 2024 May; 38(3):167-177. PubMed ID: 38619789
[TBL] [Abstract][Full Text] [Related]
15. Additional qualifications of trainees in specialist training programs in Australia.
Thompson D; Thompson C; Nassar N; Katelaris A
BMC Med Educ; 2019 Jul; 19(1):247. PubMed ID: 31277625
[TBL] [Abstract][Full Text] [Related]
16. Managerial implications of medical sales representative perceptions of job duties, job qualifications, and other performance-related issues.
Tengilimoğlu D; Korkmaz S; Akinci F; Parsons AL
Health Mark Q; 2004; 22(2):3-26. PubMed ID: 15914372
[TBL] [Abstract][Full Text] [Related]
17. How Do Pharmaceutical Companies Overcome a Corporate Productivity Crisis? Business Diversification into Medical Devices for Growth Potential.
Euh Y; Lee D
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503944
[TBL] [Abstract][Full Text] [Related]
18. The multiple stakeholder approach to real-world evidence (RWE) generation: observing multidisciplinary expert consensus on quality indicators of rare disease patient registries (RDRs).
Jandhyala R
Curr Med Res Opin; 2021 Jul; 37(7):1249-1257. PubMed ID: 33989087
[TBL] [Abstract][Full Text] [Related]
19. Digital Medical Information Services Delivered by Pharmaceutical Companies via WeChat: Qualitative Analytical Study.
Ge Y; Yao D; Ung COL; Xue Y; Li M; Lin J; Hu H; Lai Y
J Med Internet Res; 2023 Nov; 25():e43812. PubMed ID: 37976079
[TBL] [Abstract][Full Text] [Related]
20. How pharmaceutical industry employees manage competing commitments in the face of public criticism.
Lipworth W; Montgomery K; Little M
J Bioeth Inq; 2013 Oct; 10(3):355-67. PubMed ID: 23744524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
